97. Ulcerative colitis Clinical trials / Disease details

Clinical trials : 2,527 /  Drugs : 1,465 - (DrugBank : 259) / Drug target genes : 144 - Drug target pathways : 202

  
1 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1EUCTR2019-002485-12-IT
(EUCTR)		23/09/202122/10/2020Determination of the Optimal Treatment Target in Ulcerative ColitisVERDICT: In actiVE ulcerative colitis, a RanDomIzed Controlled Trial for determination of the optimal treatment target - VERDICT Ulcerative Colitis (UC)
MedDRA version: 20.1;Level: LLT;Classification code 10045365;Term: Ulcerative colitis;System Organ Class: 100000004856;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]		Trade Name: Entyvio
Product Name: Entyvio
Product Code: [NA]
Other descriptive name: VEDULIZUMAB
Trade Name: Entyvio
Product Name: Entyvio
Product Code: [NA]
Other descriptive name: VEDOLIZUMAB		ALIMENTIV INC.NULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes		660Phase 4United States;France;Belarus;Canada;Poland;Belgium;Ukraine;Russian Federation;Netherlands;United Kingdom;Italy